These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 8687094)

  • 41. High prevalence of HER-2/neu and p53 overexpression in inflammatory breast cancer.
    Sawaki M; Ito Y; Akiyama F; Tokudome N; Horii R; Mizunuma N; Takahashi S; Horikoshi N; Imai T; Nakao A; Kasumi F; Sakamoto G; Hatake K
    Breast Cancer; 2006; 13(2):172-8. PubMed ID: 16755113
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differential gene expression patterns in HER2/neu-positive and -negative breast cancer cell lines and tissues.
    Wilson KS; Roberts H; Leek R; Harris AL; Geradts J
    Am J Pathol; 2002 Oct; 161(4):1171-85. PubMed ID: 12368191
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunofluorometric analysis of p53 protein and prostate-specific antigen in breast tumours and their association with other prognostic indicators.
    Levesque MA; Clark GM; Yu H; Diamandis EP
    Br J Cancer; 1995 Sep; 72(3):720-7. PubMed ID: 7545416
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer.
    Allred DC; Clark GM; Elledge R; Fuqua SA; Brown RW; Chamness GC; Osborne CK; McGuire WL
    J Natl Cancer Inst; 1993 Feb; 85(3):200-6. PubMed ID: 8423624
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Coexpression of HER-2/neu and p53 in breast cancer identifies a subset with an aggressive biopathological profile.
    Sidoni A; Cavaliere A; Bellezza G; Del Sordo R; Angiero F; Gori S; Rulli A; Bucciarelli E
    Tumori; 2006; 92(5):412-5. PubMed ID: 17168434
    [TBL] [Abstract][Full Text] [Related]  

  • 46. P-glycoprotein, HER-2/neu, and mutant p53 expression in human gynecologic tumors.
    Schneider J; Rubio MP; Barbazán MJ; Rodriguez-Escudero FJ; Seizinger BR; Castresana JS
    J Natl Cancer Inst; 1994 Jun; 86(11):850-5. PubMed ID: 7910219
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The combination of p53 mutation and neu/erbB-2 amplification is associated with poor survival in node-negative breast cancer.
    Bull SB; Ozcelik H; Pinnaduwage D; Blackstein ME; Sutherland DA; Pritchard KI; Tzontcheva AT; Sidlofsky S; Hanna WM; Qizilbash AH; Tweeddale ME; Fine S; McCready DR; Andrulis IL
    J Clin Oncol; 2004 Jan; 22(1):86-96. PubMed ID: 14701769
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adenoid cystic carcinoma of the trachea and bronchus--a clinicopathologic study with DNA flow cytometric analysis and oncogene expression.
    Lin CM; Li AF; Wu LH; Wu YC; Lin FC; Wang LS
    Eur J Cardiothorac Surg; 2002 Oct; 22(4):621-5. PubMed ID: 12297183
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The DCC protein expression in breast carcinoma.
    Hsu YH; Shaw CK
    Kaohsiung J Med Sci; 2000 May; 16(5):233-40. PubMed ID: 10969518
    [TBL] [Abstract][Full Text] [Related]  

  • 50. p53 protein expression in breast cancer as related to histopathological characteristics and prognosis.
    Lipponen P; Ji H; Aaltomaa S; Syrjänen S; Syrjänen K
    Int J Cancer; 1993 Aug; 55(1):51-6. PubMed ID: 8344753
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression of p53 and HER2/Neu in Kenyan Women With Primary Ovarian Carcinoma.
    Mutuiri AP; Nzioka A; Busarla SV; Sayed S; Moloo Z
    Int J Gynecol Pathol; 2016 Nov; 35(6):537-543. PubMed ID: 26825003
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Higher expression of oncoproteins c-myc, c-erb B-2/neu, PCNA, and p53 in metastasizing colorectal cancer than in nonmetastasizing tumors.
    Yang JL; Ow KT; Russell PJ; Ham JM; Crowe PJ
    Ann Surg Oncol; 1996 Nov; 3(6):574-9. PubMed ID: 8915491
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic indicators for neuroblastoma: stage, grade, DNA ploidy, MIB-1-proliferation index, p53, HER-2/neu and EGFr--a survival study.
    Layfield LJ; Thompson JK; Dodge RK; Kerns BJ
    J Surg Oncol; 1995 May; 59(1):21-7. PubMed ID: 7745972
    [TBL] [Abstract][Full Text] [Related]  

  • 54. p53 protein and vimentin in invasive ductal NOS breast carcinoma--relationship with survival and sites of metastases.
    Domagala W; Striker G; Szadowska A; Dukowicz A; Harezga B; Osborn M
    Eur J Cancer; 1994; 30A(10):1527-34. PubMed ID: 7833113
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Re: erbB-2, p53, and efficacy of adjuvant therapy in lymph node-positive breast cancer.
    Cameron DA; Leonard RC
    J Natl Cancer Inst; 1999 Apr; 91(8):728-9. PubMed ID: 10218517
    [No Abstract]   [Full Text] [Related]  

  • 56. Immunocytochemical p53 detection by microwave oven heating of routinely formalin-fixed paraffin sections.
    Campani D; Cecchetti D; Bevilacqua G
    J Pathol; 1993 Oct; 171(2):151-2. PubMed ID: 8283352
    [No Abstract]   [Full Text] [Related]  

  • 57. Pancreatic endocrine tumors-c-erb B2 (Her-2/neu), bcl-2, and p-53 immunohistochemical testing and their value in assessing prognosis.
    Proca DM; Frankel WL
    Appl Immunohistochem Mol Morphol; 2008 Jan; 16(1):44-7. PubMed ID: 18091321
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lack of prognostic value of p53 protein expression in node-negative breast cancer.
    Bianchi S; Calzolari A; Vezzosi V; Zampi G; Cardona G; Cataliotti L; Bonardi R; Ciatto S
    Tumori; 1997; 83(3):669-72. PubMed ID: 9267486
    [TBL] [Abstract][Full Text] [Related]  

  • 59. p53 expression and resistance against paclitaxel in patients with metastatic breast cancer.
    Schmidt M; Bachhuber A; Victor A; Steiner E; Mahlke M; Lehr HA; Pilch H; Weikel W; Knapstein PG
    J Cancer Res Clin Oncol; 2003 May; 129(5):295-302. PubMed ID: 12715164
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Management of port-site metastasis after laparoscopic surgery for ovarian cancer.
    Huang KG; Wang CJ; Chang TC; Liou JD; Hsueh S; Lai CH; Huang LW
    Am J Obstet Gynecol; 2003 Jul; 189(1):16-21. PubMed ID: 12861132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.